Professor Oliver Hantschel​ 
​ Chronic Myeloid Leukemia    CML


​Professor Oliver Hantschel

Since January 2020, Professor Hantschel is Director of the Institute for Physiological Chemistry, Chair of Biochemistry, Faculty of Medicine, Philipps University of Marburg in Germany. As a translational cancer researcher with expertise in biochemistry, drug action, structural biology and protein engineering, Dr Hantschel’s work focuses on the elucidation of molecular mechanisms of oncogenesis in order to find new concepts and approaches for the development of new therapeutic approaches.
With a strong focus on tyrosine kinase oncoproteins, The Hantschel lab uses interdisciplinary approaches at the intersection of protein biochemistry, structural biology, protein engineering, molecular oncology, proteomics and chemical biology to study cell signalling in leukaemias with the aim of finding new avenues for therapeutic interventions.
More informations at The 2022 Rowley Prize is awarded to Professor Oliver Hantschel - iCMLf